CD1A and common variable immunodeficiency: Moreover, in vitro studies showed that different concentrations of IVIg added to MdDC influenced the expression pattern of CD1 molecules (28); similarly, in vivo studies found that IVIg therapy normalized the elevated levels of CD1a and CD1b on mDCs of CVID patients (29).